12 Covid-19 vaccines to watch

A range of Covid-19 vaccines are being developed worldwide. Which ones are authorised and assessed in the EU? Which are still in development? Check our table below.

Company Type Efficacy* Doses Storage Status in Europe* Secured by EU

Pfizer / BioNTech πŸ‡©πŸ‡ͺπŸ‡ΊπŸ‡Έ

mRNA*

πŸ’‰πŸ’‰ (πŸ’‰)

2.4 bn
Moderna πŸ‡ΊπŸ‡Έ
mRNA

πŸ’‰πŸ’‰ (πŸ’‰)

-20Β°C
460 mn
AstraZeneca / Oxford πŸ‡ΈπŸ‡ͺπŸ‡¬πŸ‡§
Adenovirus-vectored technology*
πŸ’‰πŸ’‰
Fridge
400 mn
Johnson&Johnson / Janssen πŸ‡§πŸ‡ͺπŸ‡ΊπŸ‡Έ
Adenovirus-vectored technology
πŸ’‰
Fridge
400 mn
Novavax πŸ‡ΈπŸ‡ͺπŸ‡ΊπŸ‡Έ
Protein

89.3%

πŸ’‰πŸ’‰
Fridge
~200 mn
CVnCoV - CureVac AG πŸ‡©πŸ‡ͺ
mRNA
❔
πŸ’‰πŸ’‰
Fridge
405 mn
Sputnik V - Gamaleya Research Institute πŸ‡·πŸ‡Ί
Adenovirus-vectored technology

πŸ’‰πŸ’‰

-18Β°C

Rolling review Emergency use in Hungary, BiH, Serbia, Montenegro

CoronaVac - Sinovac πŸ‡¨πŸ‡³
Inactivated virus
πŸ’‰πŸ’‰
Fridge

Rolling review Emergency use in Turkey

BBIBP-CorV - Sinopharm πŸ‡¨πŸ‡³
Inactivated virus
πŸ’‰πŸ’‰
Fridge
Emergency use in Hungary, Serbia
VLA2001 - Valneva πŸ‡«πŸ‡·
Inactivated virus
❔
❔
Fridge
~60 mn

Sanofi & GSK πŸ‡«πŸ‡· (x2 vaccines)

mRNA & protein
❔
❔
❔

Rolling review of Vidprevtyn
(protein-based vaccine)

300 mn

β€’ Efficacy: numbers vary in different sources
β€’ mRNA: messenger RNA, part of the virus’ genetic code
β€’ Adenovirus-vectored technology: genetically modified cold virus
β€’ Status in Europe: overview of the situation in EU and in the candidates/potential candidates countries.

Sources: WHO, EMA, EC, Astrazeneca, Sanofi, JnJ, Novavax, SputnikVaccine, TheLancet, Nature & other.

Last update : 29 June 2022